SEC 13F Intelligence

Athyrium Capital Management, LP / PBYI

Athyrium Capital Management, LP’s Puma Biotechnology Inc Position

Does Athyrium Capital Management, LP own Puma Biotechnology Inc (PBYI)? Yes — 1.26M shares worth $3M (+36.88% of its 13F portfolio) as of Q3 2024.

Position Value
$3M
Q3 2024
Shares
1.26M
% of Portfolio
+36.88%
Quarters Held
11
currently held

Position History PBYI

Reported value by quarter
Q1 ’22: $5MQ1 ’22Q2 ’22: $5MQ3 ’22: $4MQ3 ’22Q4 ’22: $8MQ1 ’23: $6MQ1 ’23Q2 ’23: $6MQ3 ’23: $5MQ3 ’23Q4 ’23: $8MQ1 ’24: $7MQ1 ’24Q2 ’24: $4MQ3 ’24: $3MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20241.26M$3M+36.88%
Q2 20241.26M$4M+12.21%
Q1 20241.26M$7M+9.15%
Q4 20231.79M$8M+11.27%
Q3 20231.79M$5M+4.15%
Q2 20231.79M$6M+4.10%
Q1 20231.79M$6M+1.98%
Q4 20221.79M$8M+3.19%
Q3 20221.79M$4M+1.59%
Q2 20221.79M$5M+2.15%
Q1 20221.79M$5M+1.83%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Athyrium Capital Management, LP’s full portfolio or all institutional holders of PBYI.